Accurate Monitoring of Renal Injury State Through in Vivo Magnetic Resonance Imaging with Ferric Coordination Polymer Nanodots

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2018 Sep 18

PMID 30221228

Citations 1

Authors

Xiaodong Li

Hongda Chen

Fuyao Liu

Yixin Chen

Huimao Zhang

Zhenxin Wang

Affiliations

Soon will be listed here.

Abstract

It is highly challenging to detect the pathophysiology of the diseased kidneys and achieve precise diagnosis because there are few in vivo noninvasive imaging techniques to quantitatively assess kidney dysfunction. This longstanding challenge is normally attributed to the limited molecular contrast agents which can be addressed with renal clearable nanoprobes. In this report, we demonstrate the use of magnetic resonance imaging along with renal clearable ferric coordination polymer nanodots (Fe-CPNDs) for in vivo monitoring the kidney dysfunction effects following drug (daunomycin)-induced kidney injury. After intravenous injection of Fe-CPNDs, the change of the MR signal in the kidney can be precisely correlated with local pathological lesion which is demonstrated by renal anatomic details and biochemical examinations of urine and blood. This finding opens the door to the possibility of noninvasively assessing kidney dysfunction and local injuries.

Citing Articles

The Renal Clearable Magnetic Resonance Imaging Contrast Agents: State of the Art and Recent Advances.

Li X, Sun Y, Ma L, Liu G, Wang Z Molecules. 2020; 25(21).

PMID: 33139643 PMC: 7662352. DOI: 10.3390/molecules25215072.

References

Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A . Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Biomed Res Int. 2014; 2014:362725. PMC: 4150431. DOI: 10.1155/2014/362725. View

Xu J, Yu M, Carter P, Hernandez E, Dang A, Kapur P . In Vivo X-ray Imaging of Transport of Renal Clearable Gold Nanoparticles in the Kidneys. Angew Chem Int Ed Engl. 2017; 56(43):13356-13360. PMC: 5909191. DOI: 10.1002/anie.201707819. View

Hall A, Molitoris B . Dynamic multiphoton microscopy: focusing light on acute kidney injury. Physiology (Bethesda). 2014; 29(5):334-42. PMC: 4214830. DOI: 10.1152/physiol.00010.2014. View

Toth G, Varallyay C, Horvath A, Bashir M, Choyke P, Daldrup-Link H . Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. Kidney Int. 2017; 92(1):47-66. PMC: 5505659. DOI: 10.1016/j.kint.2016.12.037. View

Liu F, He X, Chen H, Zhang J, Zhang H, Wang Z . Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications. Nat Commun. 2015; 6:8003. PMC: 4918390. DOI: 10.1038/ncomms9003. View

Yu M, Liu J, Ning X, Zheng J . High-contrast Noninvasive Imaging of Kidney Clearance Kinetics Enabled by Renal Clearable Nanofluorophores. Angew Chem Int Ed Engl. 2015; 54(51):15434-8. PMC: 4715620. DOI: 10.1002/anie.201507868. View

Shin M, Matsunaga H, Fujiwara K . Differences in accumulation of anthracyclines daunorubicin, doxorubicin and epirubicin in rat tissues revealed by immunocytochemistry. Histochem Cell Biol. 2010; 133(6):677-82. DOI: 10.1007/s00418-010-0700-3. View

Grobner T . Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant. 2006; 21(4):1104-8. DOI: 10.1093/ndt/gfk062. View

Tombach B, Heindel W . Value of 1.0- M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol. 2002; 12(6):1550-6. DOI: 10.1007/s00330-001-1242-9. View

10.

Rob S, Bryant T, Wilson I, Somani B . Ultra-low-dose, low-dose, and standard-dose CT of the kidney, ureters, and bladder: is there a difference? Results from a systematic review of the literature. Clin Radiol. 2016; 72(1):11-15. DOI: 10.1016/j.crad.2016.10.005. View

11.

Williams R, Jaimes E, Heller D . Nanomedicines for kidney diseases. Kidney Int. 2016; 90(4):740-5. PMC: 5064150. DOI: 10.1016/j.kint.2016.03.041. View

12.

van Eijs M, van Zuilen A, de Boer A, Froeling M, Nguyen T, Joles J . Innovative Perspective: Gadolinium-Free Magnetic Resonance Imaging in Long-Term Follow-Up after Kidney Transplantation. Front Physiol. 2017; 8:296. PMC: 5432553. DOI: 10.3389/fphys.2017.00296. View

13.

Tofts P, Cutajar M, Mendichovszky I, Peters A, Gordon I . Precise measurement of renal filtration and vascular parameters using a two-compartment model for dynamic contrast-enhanced MRI of the kidney gives realistic normal values. Eur Radiol. 2012; 22(6):1320-30. DOI: 10.1007/s00330-012-2382-9. View

14.

Tewes S, Gueler F, Chen R, Gutberlet M, Jang M, Meier M . Functional MRI for characterization of renal perfusion impairment and edema formation due to acute kidney injury in different mouse strains. PLoS One. 2017; 12(3):e0173248. PMC: 5358739. DOI: 10.1371/journal.pone.0173248. View

15.

Ympa Y, Sakr Y, Reinhart K, Vincent J . Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med. 2005; 118(8):827-32. DOI: 10.1016/j.amjmed.2005.01.069. View

16.

Marckmann P, Skov L, Rossen K, Dupont A, Damholt M, Heaf J . Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 2006; 17(9):2359-62. DOI: 10.1681/ASN.2006060601. View

17.

Chawla L, Eggers P, Star R, Kimmel P . Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014; 371(1):58-66. PMC: 9720902. DOI: 10.1056/NEJMra1214243. View

18.

Zhang J, Rusinek H, Chandarana H, Lee V . Functional MRI of the kidneys. J Magn Reson Imaging. 2013; 37(2):282-93. PMC: 3558841. DOI: 10.1002/jmri.23717. View

19.

Sternberg S . Cross-striated fibrils and other ultrastructural alterations in glomeruli of rats with daunomycin nephrosis. Lab Invest. 1970; 23(1):39-51. View

20.

McArthur C, Baxter G . Current and potential renal applications of contrast-enhanced ultrasound. Clin Radiol. 2012; 67(9):909-22. DOI: 10.1016/j.crad.2012.01.017. View